Abbott Quarterly Earnings Beat Estimates on Device Sales

  • All four business units reported revenue gains for period
  • CEO White wants more Alere data; ‘fair amount’ not provided

Abbott Laboratories, embroiled in a contentious acquisition of the medical testing company Alere Inc., said second-quarter profit topped analysts’ estimates as device demand led rising sales across all four of its business segments. 

To continue reading this article you must be a Bloomberg Professional Service Subscriber.